BiotechTube
Home/Interactome Biotherapeutics/James T. Secrest, MS, DC
JT

James T. Secrest, MS, DC

Director, Research and Development

Interactome Biotherapeutics

Therapeutic Areas

NeurologyOncologyCardiologyRare Disease

Interactome Biotherapeutics Pipeline

DrugIndicationPhase
IB001Nerve InjuryPre-clinical

Leadership Team at Interactome Biotherapeutics

AK
Adam Koster
CEO, Co-Founder
FN
Frederick Naftolin, MD, PhD
Co-Founder, Vice President
AH
Ahvie Herskowitz, MD
Chief Medical Officer, Chair, Medical & Scientific Advisory Board
View full Interactome Biotherapeutics profile